● Recruiting

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Condition: B-cell Malignancy · Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Sponsor: Carna Biosciences, Inc.

PhasePhase 1

Planned participants120

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is an open-label, multi-center Phase 1b clinical study of oral AS-1763 (docirbrutinib) in patients with CLL/SLL or B-cell NHL who have failed or are intolerant to ≥2 lines of systemic therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Akinori Arimura, PhD · 650-636-4603 · clinical_us@dd.carnabio.com

Always discuss trial participation with your own doctor first.

Locations (13)

UC Irvine Health	Orange, California, United States	Recruiting
Mount Sinai Comprehensive Cancer Center	Miami Beach, Florida, United States	Recruiting
Moffitt Cancer Center	Tampa, Florida, United States	Recruiting
Northwestern Memorial Hospital	Chicago, Illinois, United States	Recruiting
American Oncology Partners	Fort Wayne, Indiana, United States	Recruiting
University of Maryland Medical Center - Greenebaum Comprehensive Cancer Center	Baltimore, Maryland, United States	Recruiting
University of Massachusetts Memorial Medical Center	Worcester, Massachusetts, United States	Recruiting
Optum Medical Care PC	Westbury, New York, United States	Recruiting
Duke University	Durham, North Carolina, United States	Recruiting
Taylor Cancer Research Center	Maumee, Ohio, United States	Recruiting
Oncology Consultants	Houston, Texas, United States	Recruiting
University of Texas MD Anderson Cancer Center	Houston, Texas, United States	Recruiting

+ 1 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05602363